Cover Image
Market Research Report

Tumor Marker Testing Technologies and Strategic Profiles of Leading Suppliers

Published by Venture Planning Group Product code 251434
Published Content info 185 Pages
Delivery time: 1-2 business days
Price
Back to Top
Tumor Marker Testing Technologies and Strategic Profiles of Leading Suppliers
Published: Content info: 185 Pages
Description

This 185-page report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for tumor markers technologies. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.

The report also presents strategic assessments of current and emerging suppliers of tumor marker diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. 

Contains 185 pages

Table of Contents
Product Code: VPTM19086

Table of Contents

Current and Emerging Technologies

Monoclonal and Polyclonal Antibodies

Immunoassays

  • a. Technological Principle
  • b. Radioimmunoassay (RIA)
  • c. Enzyme Immunoassays (EIA)
    • Overview
    • ELISA
    • Immunofiltration
    • Particle-Membrane Capture Immunoassay
    • Enzyme Amplification
  • d. Fluorescent Immunoassays
  • e. Luminescence
    • Chemiluminescence
    • Bioluminescence
  • f. Latex Agglutination
  • g. Immunoprecipitation
  • H. Affinity Chromatographu
  • e. Liposome Flow-Injection Immunoassay

Molecular Diagnostics

  • a. Technology Overview
  • b. Amplification Methods
    • PCR
    • DAP-PCR
    • Immuno-PCR
    • QC-PCR
    • CAR
    • DNA
    • HPA
    • LCR
    • NASBA
    • QBR
    • SDA
    • 3 SR, and others

Chromosome Analysis

  • a. Chronic Myelogenous Leukemia (CML)
  • b. Acute Myeloid Leukemia (AML)
  • c. Acute Lymphoblastic Leukemia (ALL)
  • d. Malignant Lymphomas Lymphoid Malignancies
  • e. Chronic Lymphocytic Leukemia (CLL)
  • f. Solid Cancers
  • g. Chromosomal Translocation and Oncogenes

Artificial Intelligence

Flow Cytometry

Two Dimensional Gel Electrophoresis (2-DGE)

Biosensors

Competing/Complementing Technologies

  • a. CT
  • b. MRI
  • c. NMR
  • d. PET
  • e. Photonics Spectroscopy

Competitive Profiles

  • Abbott
  • AdnaGen
  • Applied Gene Technologies
  • Arca
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Correlogic Systems
  • Dako
  • Decode
  • Diadexus
  • Diagnocure
  • Diasorin
  • Eiken Chemical
  • Enterix
  • Enzo Biochem
  • Epigenomics
  • Exact Sciences
  • Fujirebio
  • Gen-Probe
  • Guided Therapeutics
  • Hologic
  • Ipsogen
  • Kreatech
  • Kyowa Medex
  • Life Technologies
  • Mackay Life Sciences
  • Myriad Genetics
  • Nanogen.Elitech
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • Takara Bio
  • Targeted Diagnostics & Therapeutics
  • Tosoh
  • Veridex
  • Wako Pure Chemicals
  • Wallac/PE
  • Zila
Back to Top